2nd Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$380,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Education regarding the existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Taxation/Internal Revenue Code TAX

Meetings/education regarding the implementation of new medical device tax. Meetings/education regarding proposals to repeal LIFO.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Meetings/education regarding incentives for health informatoin technology, Affordable Care Act implementation and other healthcare policy issues. Proposed regulation of medical software. Various issues in the Food and Drug Administration Safety and Innovation Act. H.R. 2746, the Cancer Drug Coverage Parity Act. S. 752, the Lung Cancer Mortality Reduction Act.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
KEAGAN R LENIHAN —
GEOFF WERTH —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2746 (112th), S. 752 (112th)

Medicare/Medicaid MMM

H.R. 905/S.733, to amend Part B of title XVIII of the Social Security Act. Meetings/education regarding physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
KEAGAN R LENIHAN —
GEOFF WERTH —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 905 (112th), S. 733 (112th)

Pharmacy PHA

Meetings/education regarding pharmacy issues. Prescription drug supply chain issues, including security of the supply chain and other related issues. Various issues in the Food and Drug Administration Safety and Innovation Act.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.